Novo Nordisk will lower its insulin list prices by up to 75% in the U.S. Insulin costs in the U.S. are higher than other parts of the world. The move follows Eli Lilly’s earlier decision to lower costs.
Following Eli Lilly, drugmaker Novo Nordisk announces cuts to insulin prices
